Bioscript is a successful integrated, healthcare communications group to pharmaceutical and biotech companies. Sovereign has partnered with the management team to significantly increase its geographic footprint and extend into adjacent strategic services.
Bioscript Group is one of the largest independent global agencies, with a strong international reputation for high-quality medical communications, regulatory writing and market access consultancy. The business assists clients in their communications with regulatory authorities as well as educating the medical sector on pharmaceutical products that are in mid- to late-stage clinical trials and subsequently supporting these products, post market launch, to maintain and grow sales throughout the lifecycle of the drug.
Acquisitions to Date
The Business Today
The acquisitions have strengthened Bioscript’s end-to-end service offering by extending the breadth and depth of its services across the pharmaceutical product lifecycle, and have brought additional capabilities in medical affairs, global market access strategy and payer value communications. The combined group brings together more than 220 dedicated experts in healthcare communications globally with a focus on scientific and writing excellence, expert engagement, events management, strategic planning, and patient access consulting, for pharmaceutical and biotech companies. Today the Group also provide clients with extended support across integrated medical communication programmes from very early clinical development through to market access communications.
Sovereign is working with the management team to further develop and grow the business.
Since partnering with Sovereign, we have been delighted with the M&A opportunities the team have brought and helped us to transact. The acquisitions will enable us to build upon our extensive, integrated services at a time when increasing trial complexity, regulatory demands and pricing pressures require a fully joined-up, cross-functional approach.
Andrew Medley / Founder & CEO / Bioscript